Relapsed/Refractory Acute Leukemia
Oncology·MeSH: Leukemia
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| Revumenib | Syndax Pharmaceuticals Inc (SNDX) |
Frequently asked questions
How many drugs are in development for Relapsed/Refractory Acute Leukemia?
BioSniper tracks 1 drug in development for Relapsed/Refractory Acute Leukemia across 1 company.
How many clinical trials target Relapsed/Refractory Acute Leukemia?
There are 1 clinical trial targeting Relapsed/Refractory Acute Leukemia tracked by BioSniper.
Deep-dive into Relapsed/Refractory Acute Leukemia
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis